Videos
Advertisement
Advertisement
Trending on Urology Times
1
Enzalutamide plus salvage radiotherapy associated with improved PFS in high-risk BCR
2
Behind the FDA approval of belzutifan plus lenvatinib in advanced ccRCC, with Robert Motzer, MD
3
SBRT, prostatectomy show comparable long-term disease control in PACE-A trial
4
Closing Risk Stratification Gaps in Localized Prostate Cancer With AI
5